Personalis, Inc. logo

Personalis, Inc.

NASDAQ:PSNL

Overview | Financials
Company Name Personalis, Inc.
Symbol PSNL
Currency USD
Price 4.88
Market Cap 431,026,488
Dividend Yield 0%
52-week-range 1.135 - 7.2
Industry Diagnostics & Research
Sector Healthcare
CEO Mr. Christopher M. Hall
Website https://www.personalis.com

An error occurred while fetching data.

About Personalis, Inc.

Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or plasma

Related Stocks

Sanara MedTech Inc. logo

Sanara MedTech Inc.

SMTI

29.17 USD

Lyra Therapeutics, Inc. logo

Lyra Therapeutics, Inc.

LYRA

27.58 USD

MoonLake Immunotherapeutics logo

MoonLake Immunotherapeutics

MLTX

48.55 USD

Tactile Systems Technology, Inc. logo

Tactile Systems Technology, Inc.

TCMD

10.28 USD

Marinus Pharmaceuticals, Inc. logo

Marinus Pharmaceuticals, Inc.

MRNS

0.55 USD

Pliant Therapeutics, Inc. logo

Pliant Therapeutics, Inc.

PLRX

1.6 USD

DermTech, Inc. logo

DermTech, Inc.

DMTK

0.094 USD

Immunic, Inc. logo

Immunic, Inc.

IMUX

0.73 USD

Kronos Bio, Inc. logo

Kronos Bio, Inc.

KRON

0.68 USD

Rapid Micro Biosystems, Inc. logo

Rapid Micro Biosystems, Inc.

RPID

3.73 USD

Financials

Numbers are in millions USD

Numbers are in millions USD